Trial Profile
Intravitreal bevacizumab injection for intraocular neovascularization in children
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 27 Dec 2021 Status changed from recruiting to discontinued.
- 10 Jul 2014 New trial record